3229-1123 Screening compound: 2-[(E)-{2-[4,6-bis(morpholin-4-yl)-1,3,5-triazin-2-yl]hydrazin-1-ylidene}methyl]-4-bromophenol

3229-1123 Screening compound: 2-[(E)-{2-[4,6-bis(morpholin-4-yl)-1,3,5-triazin-2-yl]hydrazin-1-ylidene}methyl]-4-bromophenol
3229-1123 Screening compound: 2-[(E)-{2-[4,6-bis(morpholin-4-yl)-1,3,5-triazin-2-yl]hydrazin-1-ylidene}methyl]-4-bromophenol alternative view

Chemical Structure Depiction of ChemDiv screening compound 3229-1123
2-[(E)-{2-[4,6-bis(morpholin-4-yl)-1,3,5-triazin-2-yl]hydrazin-1-ylidene}methyl]-4-bromophenol

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

3229-1123

Molecular Formula

C18H22BrN7O3 (C18 H22 BrN7 O3)

Compound Name

2-[(E)-{2-[4,6-bis(morpholin-4-yl)-1,3,5-triazin-2-yl]hydrazin-1-ylidene}methyl]-4-bromophenol

IUPAC name

2-[(E)-{2-[46-bis(morpholin-4-yl)-135-triazin-2-yl]hydrazin-1-ylidene}methyl]-4-bromophenol

SMILES

Oc(cc1)c(/C=N/Nc2nc(N3CCOCC3)nc(N3CCOCC3)n2)cc1Br

InChI

InChI=1S/C18H22BrN7O3/c19-14-1-2-15(27)13(11-14)12-20-24-16-21-17(25-3-7-28-8-4-25)23-18(22-16)26-5-9-29-10-6-26/h1-2,11-12,27H,3-10H2,(H,21,22,23,24)

InChI Key

IXDISRVXXCZRGY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD00348112

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

464.32

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

4.239

Distribution Coefficient, logD

4.221

Water Solubility, LogSw

-3.91

Polar Surface Area

89.500

Acid Dissociation Constant (pKa)

9.20

Base Dissociation Constant (pKb)

5.82

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

44.40

3229-1123 in Drug Discovery

Included in Screening Libraries

Autophagy-Targeted Library (4564 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system

References: we are preparing a list of scientific research reports with 3229-1123 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 3229-1123?
Check Price and Availability of 3229-1123, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 3229-1123 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 3229-1123
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 3229-1123
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 3229-1123 available by request